Cargando…
Combining Engineered U1 snRNA and Antisense Oligonucleotides to Improve the Treatment of a BBS1 Splice Site Mutation
Manipulation of pre-mRNA processing is a promising approach toward overcoming disease-causing mutations and treating human diseases. We show that a combined treatment applying two splice-manipulating technologies improves therapeutic efficacies to correct mutation-induced splice defects. Previously,...
Autores principales: | Breuel, Saskia, Vorm, Mariann, Bräuer, Anja U., Owczarek-Lipska, Marta, Neidhardt, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6796732/ https://www.ncbi.nlm.nih.gov/pubmed/31541798 http://dx.doi.org/10.1016/j.omtn.2019.08.014 |
Ejemplares similares
-
Autosomal dominant optic atrophy: A novel treatment for OPA1 splice defects using U1 snRNA adaption
por: Jüschke, Christoph, et al.
Publicado: (2021) -
In Vivo Efficacy and Safety Evaluations of Therapeutic Splicing Correction Using U1 snRNA in the Mouse Retina
por: Swirski, Sebastian, et al.
Publicado: (2023) -
U5 snRNA Interactions With Exons Ensure Splicing Precision
por: Artemyeva-Isman, Olga V., et al.
Publicado: (2021) -
Chemical Synthesis of U1 snRNA Derivatives
por: Ohkubo, Akihiro, et al.
Publicado: (2013) -
Recognition of atypical 5' splice sites by shifted base-pairing to U1 snRNA
por: Roca, Xavier, et al.
Publicado: (2009)